Instituto de Biomedicina y Biotecnología de Cantabria

Humanized anti-BAMBI monoclonal antibody as a novel therapeutic strategy for psoriatic arthritis

Psoriasis (PsO) is a chronic autoimmune skin disease that affects 2% of the global population, with 30% of patients progressing to psoriatic arthritis (PsA). Both conditions are primarily mediated by CD4 + T cells, whose differentiation into distinct subpopulations depends on the...